CSPC Pharmaceutical Group Ltd

01093

Company Profile

  • Business description

    CSPC Pharmaceutical Group listed on the Hong Kong Stock Exchange in 1994 and is one of the largest pharmaceutical companies in China. Its biggest business segment is the finished drugs segment which accounts for nearly 80% of its total revenue. Now it has a diversified pipeline portfolio in seven therapeutic areas including nervous system diseases, oncology, anti-infective to cardiovascular disease, respiratory system disease, and metabolism. CSPC also has a bulk drug product segment including vitamin C, antibiotics, and a caffeine series.

  • Contact

    No. 226 Huanghe Street
    Hebei Province
    Shijiazhuang050035
    CHN

    T: +86 31187037015

    https://www.cspc.com.hk

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 December 2024

    Employees

    20,300

Stocks News & Analysis

stocks

Undervalued ASX share hampered by delays in foreign expansion

A near monopoly in Australia pushes this company into global markets but progress has been slow.
stocks

Ask the analyst: Why has MinRes fallen so far?

Mineral Resources shares are down almost 50% year to date. Mark Taylor weighs in on some of the reasons why.
stocks

The largest ASX company is materially overvalued

After a 37% share price increase in the last 12 months, investors may be too optimistic for this ASX giant 

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,512.106.80-0.08%
CAC 407,426.8888.211.20%
DAX 4019,448.60233.121.21%
Dow JONES (US)44,293.13304.140.69%
FTSE 1008,125.1952.800.65%
HKSE19,988.18438.75-2.15%
NASDAQ19,298.7611.990.06%
Nikkei 22539,178.49354.83-0.90%
NZX 50 Index12,749.3663.030.50%
S&P 5006,001.355.810.10%
S&P/ASX 2008,254.6011.60-0.14%
SSE Composite Index3,458.3411.73-0.34%

Market Movers